These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37989113)

  • 1. Early versus Late Caffeine Therapy Administration in Preterm Neonates: An Updated Systematic Review and Meta-Analysis.
    Karlinski Vizentin V; Madeira de Sá Pacheco I; Fahel Vilas Bôas Azevêdo T; Florêncio de Mesquita C; Alvim Pereira R
    Neonatology; 2024; 121(1):7-16. PubMed ID: 37989113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
    Mitra S; Scrivens A; von Kursell AM; Disher T
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
    Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
    JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants.
    Görk AS; Ehrenkranz RA; Bracken MB
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006071. PubMed ID: 18254092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD003480. PubMed ID: 17443527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
    Jasani B; Mitra S; Shah PS
    Cochrane Database Syst Rev; 2022 Dec; 12():CD010061. PubMed ID: 36519620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.
    Kapoor V; Glover R; Malviya MN
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009172. PubMed ID: 26630252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
    Pammi M; Suresh G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007137. PubMed ID: 32232984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
    Smith LM; Qureshi N; Chao CR
    J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.
    Mosalli R; Alfaleh K
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006181. PubMed ID: 18254095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.